Introduction to the Clinical Trial Process and Gene Therapy in Hemophilia—Presented by Pfizer

This industry-sponsored educational session and meal is presented by Pfizer.

This session will serve as an introduction to clinical trials and will present a general overview of the drug development process (informed consent, inclusion/exclusion criteria, placebo, study design) and then will progress to an introduction to gene therapy trials in hemophilia.